Jonathan Schertzer (SchertzerLab) retweeted
Did the lactate metabolite family just get MUCH bigger?
Lactate has been studied for more than a century. But only in recent years have we begun exploring the metabolites that can be “spun off” from lactate.
1/5
Jonathan Schertzer (SchertzerLab) retweeted
Take a short break to review today's Mini-Review #ArticleinPress, Immunometabolism of IRF4 in Adipose, #Muscle, and Immune Cells Influences #Obesity and MASLD (Daniel Marko and Jonathan Schertzer @McMasterU):
ow.ly/BCin50Yyghs
Jonathan Schertzer (SchertzerLab) retweeted
TRIPping anti-tumour immunity through lactylation dlvr.it/TRHR2b
Jonathan Schertzer (SchertzerLab) retweeted
Insulin and adipocyte IRF4 promote fat retention over muscle preservation during intermittent fasting in obesity dlvr.it/TR7qyl
Jonathan Schertzer (SchertzerLab) retweeted
New! Online now: Lack of PCK1 in hepatic stellate cells causes liver fibrosis by fueling tricarboxylic acid cycle and increasing glycolysis dlvr.it/TR6mSR
Jonathan Schertzer (SchertzerLab) retweeted
In humans nighttime metabolic dysfunction is a hallmark of #MASLD with multiple pathogenic pathways upregulated at night, including hepatic and peripheral insulin resistance, DNL, and systemic NEFA exposure cell.com/cell-metabolism/ful… #circadian
Jonathan Schertzer (SchertzerLab) retweeted
It was a great pleasure to meet @richroll and discuss nutrition and metabolism science on the @RichRollPodcast!
This quoted post is unavailable.
Jonathan Schertzer (SchertzerLab) retweeted
Great time at the #NeurIPS2025, especially the chance to discuss our collaborative work with the @SchertzerLab and @Ali_Etemad1 and to connect with AI experts pushing time-series methods for health. I really enjoyed catching up with friends and colleagues: @Zjahed, @JWangnano
Jonathan Schertzer (SchertzerLab) retweeted

Journal of Clinical Investigation@jclinicalinvest6 Dec 2025
🇺🇸
United StatesConnected via United States App StoreAccount-level information, not a live location or per-post device.
Previously shared: Let’s GIV a NOD(2) to gut homeostasis
Here, Pradipta Ghosh & team @UCSanDiego find a critical interaction between GIV and NOD2 in gut macrophages, revealing their importance in maintaining gut health and preventing inflammatory bowel diseases (#IBD): doi.org/10.1172/JCI190851
The TEM images show phagolysosomal fusion events in infected macrophages from WT mice but not those from those lacking GIV.
Jonathan Schertzer (SchertzerLab) retweeted
Inflammation is a key driver of the pathophysiology of cardiometabolic disorders #obesity #T2D and new metabolic medicines based on GLP-1 action exert their magic in part by reducing inflammation. A new review from Professor Donath summarizes the field sciencedirect.com/science/ar…
Jonathan Schertzer (SchertzerLab) retweeted
Continuous insulin monitoring holds promise for personalized treatment strategies in diabetes management
nature.com/articles/s41551-0…
Jonathan Schertzer (SchertzerLab) retweeted
🧬 BREAKING: Our CRISPR-GPT paper is out TODAY in Nature Biomedical Engineering @natBME !
🤯 We built an AI agent that turns ANYONE into a gene-editing expert in 1 DAY instead of months. An undergrad with ZERO experience achieved 90%+ editing efficiency on their FIRST attempt.
🧵 Here's how we're building expert AI agents for cutting-edge biotechnology:
🎯 The Problem: CRISPR is revolutionary but requires PhD-level expertise, it can take weeks to learn, adopt, and design, analyze a CRISPR experiment for R&D or making life-saving medicine. Even Pro scientists can make small mistakes (e.g. typos in guideRNA or cloning design) that cost months to find out, slowing us down.
💡 Our Solution: CRISPR-GPT - an AI co-pilot from @Stanford @Princeton @GoogleDeepMind that guides you through EVERY step via simple conversation
🔬 Real Results:
-Novice researcher: ~90% editing on 1st go
-Training time: Months → 1 day
-100% success rate in our trials
-Even experts save days/weeks on data analysis & troubleshooting
🤖 How it works: Our multi-agent system handles: CRISPR system and delivery method selection, guideRNA design, Protocol generation, Real-time troubleshooting, Data analysis, and beyond. All through natural language! No coding, no complex software.
📊 We benchmarked it extensively:
-288 evaluation scenarios/cases
-Outperformed GPT-4o on ALL gene editing tasks
-Trained on 11 years of expert discussions
-Covers knockout, base-editing, prime-editing & epigenetic editing
🌍 Why this matters:
-Every lab can now use CRISPR with an AI system distilling expert knowledge and skills.
-Every student can learn faster.
-Every researcher can tackle bigger challenges without worrying about small mistakes.
-Customized CRISPR design can be automated based on your need and the context of R&D workflow.
-Agentic AI ensure safety, privacy, and responsibility
-We're not just automating gene editing - we're using AI to power scientists to cure diseases.
🚀 Try it yourself! Beta access available at: genomics.stanford.edu
Paper: nature.com/articles/s41551-0…
Code: github.com/cong-lab/crispr-g…
Benchmark (companion work, Genome-bench): github.com/mingyin0312/RL4Ge…
Co-first and key authors: @YuanhaoQ @KaixuanHuang1 @MingYin_0312
PIs: @lecong @MengdiWang10
Key collaborators: @Rbaltman @denny_zhou
The future of biology and science is conversational. The future is now. @natBME @NaturePortfolio
#CRISPR #AI #GeneEditing #Biotech #Science #AISafety
Jonathan Schertzer (SchertzerLab) retweeted
Liver cancer rates are📈in Canada, driven by #fattyliverdisease 🔗to #obesity & #diabetes. Current treatments are limited. Researchers @MacMODR & #EspervitaTherapeutics developed a drug that blocks fat production in tumors, helping #Bcells attack cancer.
Jonathan Schertzer (SchertzerLab) retweeted
New! Online now: Gut substrate trap of D-lactate from microbiota improves blood glucose and fatty liver disease in obese mice dlvr.it/TMB0yf
Jonathan Schertzer (SchertzerLab) retweeted
Replying to @APSPhysiology
@APSPhysiology hosted the symposium "The impact of diet on metabolic health and disease" on April 27th in the American Physiology Summit #APS2025 in #Baltimore.
This session was co-chaired by Dr. Weiqin Chen (@AUG_University) and Dr. Sridhar Radhakrishnan (@ResearchDiets), and the effect of #diets and nutrients on the development of #obesity, #MASLD #MASH, and liver cancer #HCC in mouse models was discussed by Dr. Jonathan Schertzer (@SchertzerLab, @BBS_McMasterU), Dr. Jose Cordoba-Chacon (@Cordoba_Lab, @Diabetes_UIC ) and Dr. Robert N. Helsley (@UKYMedicine).
@AJPEndoMetab @ajpgi @TheEndoSociety @AASLDtweets
Jonathan Schertzer (SchertzerLab) retweeted
We still don’t fully understand how people with pre-diabetes progress to diabetes — largely due to lack of tools for real-time hormone tracking. Our paper (just published in @AdvPortfolio) in collaboration with labs of @SchertzerLab and Ban tackles this gap!
#Diabeteshormones
Jonathan Schertzer (SchertzerLab) retweeted
Plant-Based Proteins: Building Muscle
For years, the fitness community held tight to the belief that animal-based proteins were superior for building muscle.
Jonathan Schertzer (SchertzerLab) retweeted
A victory that united a nation. 🇨🇦❤️
🎥 NHL & NHLPA
#4nations
Jonathan Schertzer (SchertzerLab) retweeted
Happy to share the final version of this work where we incorporated isotope labeled CO2 data into mass spec-based flux analysis framework to build a whole-body flux model of energy metabolism. Full article access here: authors.elsevier.com/a/1keM5…
@yuanbogeneral
Jonathan Schertzer (SchertzerLab) retweeted
@QuBiologics Inc. is pleased to report exciting data demonstrating that Qu Biologics’ QBECO SSI markedly improves fatty liver disease and its deleterious consequences in an animal model of preexisting obesity.
































